CORC

在结果中检索

CORC

浏览/检索结果: 共17条，第1-10条 帮助

限定条件                    
已选(0)清除 条数/页：   排序方式：
Oxaliplatin/Vincristine/Topotecan Combined with Radiofrequency Ablation in Treatment of Refractory/Recurrent Pulmonary Hepatoblastoma 会议论文
作者:  Zhang, Y.;  Chang, J.
收藏  |  浏览/下载：2/0  |  提交时间：2019/12/05
Tislelizumab Combined With Chemotherapy as First-Line Treatment in Chinese Patients With Advanced Lung Cancer 会议论文
作者:  Cui, J.;  Zhao, J.;  Wang, Z.;  Ma, Z.;  Shu, Y.
收藏  |  浏览/下载：10/0  |  提交时间：2019/12/05
External Irradiation Combined with Brachytherapy in Treatment of Invasive Maxillofacial Rhabdomyosarcoma: A Case Report 会议论文
作者:  Wang, Y.;  Chang, J.;  Wang, L.;  Wang, L.
收藏  |  浏览/下载：1/0  |  提交时间：2019/12/05
Palbociclib plus letrozole as first-line treatment for ER-positive and HER2-negative advanced breast cancer in Chinese women: a phase 1 study 会议论文
作者:  Li, Huiping;  Zhang, Qingyuan;  Li, Wei;  Wang, Shusen;  Liao, Ning
收藏  |  浏览/下载：4/0  |  提交时间：2019/12/05
OlympiAD: Further efficacy outcomes in patients with HER2-negative metastatic breast cancer and a germline BRCA mutation receiving olaparib monotherapy vs standard single-agent chemotherapy treatment of physician"s choice 会议论文
作者:  Runswick, S.;  Robson, M.;  Conte, P. F.;  Im, S-A.;  Senkus-Konefka, E.
收藏  |  浏览/下载：4/0  |  提交时间：2019/12/05
Treatment of High-Risk Neuroblastoma Over One Year of Age with Intensive and a Novel Delayed Intensification Chemotherapy 会议论文
作者:  Zhang, Y. T.;  Chang, J.;  Zhong, X. D.
收藏  |  浏览/下载：4/0  |  提交时间：2019/12/05
A Randomized, Multi-Center, Double Blind Phase II Study of Fruquintinib in Patients with Advanced Non-Small Cell Lung Cancer 会议论文
作者:  Lu, Shun;  Chang, Jianhua;  Liu, Xiaoqing;  Shi, Jianhua;  Lu, You
收藏  |  浏览/下载：4/0  |  提交时间：2019/12/05
A fatinib (A) vs erlotinib (E) as second-line treatment of patients (pts) with advanced squamous cell carcinoma (SCC) of the lung: LUX-Lung 8 (LL8), a phase III trial 会议论文
作者:  Gadgeel, Shirish;  Soria, Jean-Charles;  Felip, Enriqueta;  Cobo, Manuel;  Lu, Shun
收藏  |  浏览/下载：9/0  |  提交时间：2019/12/05
LUX-Lung 6: A randomized, open-label, phase III study of afatinib (A) vs gemcitabine/cisplatin (GC) as first-line treatment for Asian patients (pts) with EGFR mutation-positive (EGFRM plus ) advanced adenocarcinoma of the lung 会议论文
作者:  Wu, Yi-Long;  Zhou, Caicun;  Hu, Cheng-Ping;  Feng, Jifeng;  Lu, Shun
收藏  |  浏览/下载：6/0  |  提交时间：2019/12/05
TREATMENT OF CHILDREN WITH ADVANCED-STAGE LYMPHOBLASTIC LYMPHOMA WITH PEGASPARGASE 会议论文
作者:  Wang, L.;  Chang, J.;  Zhang, Y.;  Zhong, X.
收藏  |  浏览/下载：3/0  |  提交时间：2019/12/05

©版权所有 ©2017 CSpace - Powered by CSpace